×
About 8,998 results

Antibiotic Resistance Costly, Deadly for Older Americans
https://www.medscape.com/viewarticle/960873

Oct 15th, 2021 - NEW YORK (Reuters Health) - In 2017, multidrug-resistant infections led to $1.9 billion in healthcare costs, 448,224 days in the hospital and 11,852 deaths among older adults in the United States, according to a new analysis. The greatest burden was associated with infections caused by methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterobacteriaceae (CRE) and extended...

Legal, Business Groups Challenge Antitrust Charges Against DaVita Inc, Former CEO
https://www.medscape.com/viewarticle/960760

Oct 13th, 2021 - DaVita Inc, Former CEO Charged With Healthcare Labor Market Collusion A federal grand jury charged DaVita Inc and former CEO Kent Thiry for conspiring with competing employers not to try to hire certain employees. DaVita owns and operates outpatient medical care centers across the country. It focuses on dialysis and kidney care. DaVita's co-conspirator, Surgical Care Affiliates LLC and its rela...

Docs: Insurers' Payment Delays, Downcoding a 'Revenue Grab'
https://www.medscape.com/viewarticle/960786

Oct 13th, 2021 - Despite reporting record profits during the COVID-19 pandemic, major insurance companies are delaying claims payments and making it more difficult for hospitals and physicians to get paid the full amount of claims, observers and physicians say. Kaiser Health News recently reported that hospitals, in particular, are affected by the slowdown in claims payments from Anthem Blue Cross, the nation's...

The Public Backs Medicare Rx Price Negotiation Even After Hearing Both Sides' Views
https://www.medscape.com/viewarticle/960693

Oct 12th, 2021 - As Congress debates cutting prescription drug costs, a poll released Tuesday found the vast majority of adults — regardless of their political party or age — support letting the federal government negotiate drug prices for Medicare beneficiaries and those in private health insurance plans. The argument that pharmaceutical companies need to charge high prices to invest in research and develop ne...

Community Clinics Shouldered Much of the Vaccine Rollout. Many Haven't Been Paid.
https://www.medscape.com/viewarticle/960629

Oct 11th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Community clinics in California say they haven't been paid for at least 1 million covid-19 vaccine doses given since January, creating a "massive cash flow problem" for some and complicating efforts to retain staff. Clinics in other states, including Michigan and Mississippi, are also awaiting p...

CMS' 340B Reform Effort Shakes Up Hospital-Clinic Partnerships
https://www.onclive.com/view/cms-340b-reform-effort-shakes-up-hospital-clinic-partnerships

Oct 6th, 2021 - Teri U. Guidi, MBA Following a multiyear trend in which oncology practices merged with hospitals to achieve savings and improved care, it appeared as though the pendulum was going to swing the other way. The Centers for Medicare & Medicaid Services (CMS) in early 2018 changed the 340B Drug Pricing Program and reduced the outpatient drug purchasing advantage many hospitals had enjoyed over inde...

Obama Signs SGR Repeal, Heralding New Era in Medicare Reimbursement
https://www.onclive.com/view/obama-signs-sgr-repeal-heralding-new-era-in-quality-care

Oct 6th, 2021 - Blase N. Polite, MD, MPP With the flourish of a pen, President Obama put an end to a yearly nightmare of congressional budget wrangling when he signed the Medical Access and CHIP Reauthorization Act of 2015 (MACRA), otherwise known as the Sustainable Growth Rate (SGR) formula repeal. The move eliminates an unwieldy formula for determining physician Medicare payments and brings doctors a big s...

Fine Print of Budget Deal Doesn't Bode Well for SGR Overhaul
https://www.onclive.com/view/fine-print-of-budget-deal-doesnt-bode-well-for-sgr-overhaul

Oct 6th, 2021 - Ted Okon The tiny raise touted in the latest temporary fix to Medicare’s Sustainable Growth Rate (SGR), which was wrapped inside the bipartisan budget deal headed to President Obama’s desk, is anything but good news for oncologists, according to experts from two major medical associations. In fact, according to Ted Okon, executive director of the Community Oncology Alliance (COA), Congress se...

An MD and a Healthcare Exec Sued Their Employers for Fraud: What Happened?
https://www.medscape.com/viewarticle/960345

Oct 6th, 2021 - James Taylor, MD, a former physician director of coding and medical director of revenue cycle at Kaiser's Colorado Permanente Medical Group, just wanted Kaiser to do the right thing and stop submitting false claims to Medicare Advantage. Dr James Taylor Taylor, who describes himself as tenacious to a fault, says he waited 7 years to file his lawsuit because he thought he could convince Kaiser t...

Opioid Prescribing Mapped: Alabama Highest, New York Lowest
https://www.medscape.com/viewarticle/960223

Oct 4th, 2021 - Medicare beneficiaries in Alabama were more likely to get a prescription for an opioid than in any other state in 2019, based on newly released data.   That year, opioids represented 6.48% of all drug claims for part D enrollees in the state, just ahead of Utah at 6.41%. Idaho, at 6.07%, was the only other state with an opioid prescribing rate over 6%, while Oklahoma came in at an even 6.0%, ac...

Oral Anticancer Drugs Often Require Prior Authorization Leading to Treatment Delays
https://www.medscape.com/viewarticle/959873

Sep 29th, 2021 - NEW YORK (Reuters Health) - Most oral anticancer drugs require prior authorization and this often leads to delays in obtaining the medication, a new study indicates. "New health policies are needed to minimize barriers for cancer patients, with the goal of reducing time to receipt of oral anticancer drugs," Dr. Morgan Lichtenstein of Columbia NewYork-Presbyterian, in New York City, said in repo...

Fraudulent Misbranding of PPE Nets $22 Million Settlement
https://www.medscape.com/viewarticle/959848

Sep 28th, 2021 - Avanos Medical Inc to Pay $22 Million to Resolve Criminal Charge for Fraudulent Misbranding of PPE A US-based multinational medical device corporation will pay more than $22 million to resolve a criminal charge regarding fraudulent misbranding of their surgical gowns. Avanos Medical Inc, which as its US headquarters in Alpharetta, Georgia, is charged with one count of introducing misbranded sur...

Physician Shortages Blamed on Residency Policies in New Report
https://www.medscape.com/viewarticle/959711

Sep 24th, 2021 - A bottleneck in the US physician training and education pipeline limits entry into residency programs and ultimately hampers provider supply and access to care, according to a new report. The analysis, by nonpartisan think tank Niskanen Center, found that the US has "substantially fewer" physicians per capita than other developed countries. For example, the US has just 3.1 primary care physicia...

Predicted Pandemic Retirement of Many Physicians Hasn't Happened: Study
https://www.medscape.com/viewarticle/959383

Sep 23rd, 2021 - The number of physicians who have chosen early retirement or have left medicine because of the COVID-19 pandemic may be considerably lower than previously thought, results of a new study suggest. The research letter in the Journal of the American Medical Association, based on Medicare claims data, stated that "practice interruption rates were similar before and during the COVID-19 pandemic, exc...

Nurses' Union 'Dismayed' Congress Halted Medicare Drug Price Cuts
https://www.medscape.com/viewarticle/959290

Sep 22nd, 2021 - Based on early results in Congress, legislation to lower drug prices envisioned by President Joe Biden as part of his $3.5 trillion Build Back Better social-spending plan may not be an easy sell. As part of Biden's agenda unveiled last month, the plan would allow Medicare to negotiate drug prices with manufacturers to reduce prescription costs, among other reforms. National Nurses United (NNU) ...

Medicare Payments for Most Skin Procedures Dropped Over Past 15 Years
https://www.medscape.com/viewarticle/959184

Sep 21st, 2021 - Medicare reimbursement for a group of 46 common dermatologic procedures dropped by a mean of 4.8% from 2007 to 2021, after adjusting for inflation, according to a new analysis.   Large increases in mean reimbursement for skin biopsies (+30.3%) and shave removal (+24.6%) were not enough to offset lower rates for procedures such as simple repair (–38.7%), premalignant destruction (–19.6%), Mohs m...

Medicare Patients' Psoriasis, PsA Drug Costs Remain High
https://www.medscape.com/viewarticle/958854

Sep 16th, 2021 - High out-of-pocket costs for medications remain a barrier for patients with psoriasis or psoriatic arthritis on Medicare, according to findings from a cross-sectional analysis of the Centers for Medicare & Medicaid Services Prescription Drug Plan Formulary Data from the fourth quarter of 2020. Although biologics have demonstrated safety and effectiveness for psoriasis and psoriatic arthritis, t...

Fewer Inpatient Work Hours Linked With Worse Patient Outcomes
https://www.medscape.com/viewarticle/958899

Sep 16th, 2021 - The 30-day mortality rate was significantly lower among hospitalized patients treated by full-time clinicians, compared with those treated by part-time clinicians, in a new study. The number of physicians working part time in the United States has increased by nearly 11% since 1993, and as more physicians opt for part-time work, quality of care deserves further study, the investigators wrote in...

Three 'Bad News' Payment Changes Coming Soon for Physicians
https://www.medscape.com/viewarticle/958433

Sep 15th, 2021 - Physicians are bracing for upcoming changes in reimbursement that may start within a few months. As doctors gear up for another wave of COVID, payment trends may not be the top priority, but some "uh oh" announcements this fall could have far-reaching implications that could affect your future. The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule this summer covering key as...

Want to See What COVID-19 Strain You Have? The Government Says No
https://www.medscape.com/viewarticle/958713

Sep 14th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Every day, more than 140,000 people in the United States are diagnosed with COVID-19. But no matter how curious they are about which variant they are fighting, none of them will find out. The country is dotted with labs that sequence the genomes of COVID-19 cases, and the CDC tracks those result...